NEAIX | NRGEX | NEAIX / NRGEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 3 years | - |
Gain YTD | 5.139 | 2.335 | 220% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 842M | 10.5B | 8% |
Annual Yield % from dividends | 0.00 | 0.89 | - |
Returns for 1 year | 23.53 | 13.78 | 171% |
Returns for 3 years | 35.74 | -2.76 | -1,293% |
Returns for 5 years | 116.76 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IRVH | 20.06 | 0.26 | +1.31% |
Global X Interest Rt Vol & Infl Hdg ETF | |||
TILT | 221.42 | 1.59 | +0.72% |
FlexShares Mstar US Mkt Factors Tilt ETF | |||
BUFT | 22.64 | 0.05 | +0.22% |
FT Vest Buffered Allctn Dfnsv ETF | |||
SCDL | 38.79 | N/A | N/A |
ETRACS 2x Leveraged US Div Fctr TR ETN | |||
BBH | 158.18 | -0.27 | -0.17% |
VanEck Biotech ETF |